Trials / Completed
CompletedNCT01465607
Implementation of an Efficacious Intervention for High Risk Women in Mexico
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,228 (actual)
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This project seeks to determine the personal and organizational conditions that are most conducive to the widespread adoption by community-based organizations (CBOs) of effective programs for reducing the spread of HIV and other sexually transmitted infections (STIs). Taking a brief, single-session counseling program (called "Mujer Segura") that has been proven effective in reducing HIV and STIs in female sex workers who work in Mexican cities along the U.S. border, this project will study the implementation of the program in CBOs in 12 additional cities throughout Mexico to determine how best to ensure that the program remains true to the original model and retains its effectiveness. Mexico has been chosen because HIV is a global problem that respects no international borders, and because HIV prevention programs that can be implemented in settings with limited resources are urgently needed in many parts of the world.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mujer Segura | Brief (35-minute) counseling intervention using techniques from Motivational Interviewing and principles of social cognitive theory (SCT) and theory of reasoned action (TRA). |
| BEHAVIORAL | CENSIDA counseling program | Didactic HIV and STI counseling involving some personal risk assessment and presenting appropriate information on methods of transmission and for avoiding or reducing the risk of infection. Based on a counseling manual disseminated by CENSIDA, Mexico's federal HIV-AIDS prevention agency. |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2011-11-07
- Last updated
- 2015-05-27
Locations
4 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT01465607. Inclusion in this directory is not an endorsement.